Prostatic adenocarcinoma labelled with a monoclonal antibody and polyclonal serum: A quantitative assessment

British Journal of Urology

Volumn 78, Issue 1, 1996, Pages 104-108

  Gray, E ^a   Allison, L J ^a   Edgar, S ^a   Robinson, E ^a   Cohen, R J ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Epitope; Image analysis; Monoclonal; Polyclonal; Prostate specific antigen

Indexed keywords

MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN;

ANTIBODY LABELING; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; QUANTITATIVE ASSAY; TISSUE DISTRIBUTION; TISSUE SECTION;

EID: 0030391010     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1996.03820.x     Document Type: Article

References (14)

1. Feiner HD, Gonzalez R. Carcinoma of the prostate with atypical immunohistochemical features. Am JSimj Pathol 1986: 10: 765-70
2. Allhoff EP. Proppe KH. Chapman CM. Lin CW. Prout CR. Evaluation of prostate specifie acid phosphatase and prostate specific antigen in the identification of prostatic cancer. J Urol 1983; 129: 315-8
3. Bentz MS, Cohen C, Demers LM. Budgeon LR. Immunohistochemical detection of prostatic origin of metastases. Urology 1982; 19: 584-7
4. Stein BS, Petersen RO.Vangori S, Kendall AR. Immunoperoxidase localization of prostate specific antigen. Am J Surg Pathol 1982; 6: 553-5
5. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumour marker for adenocarcinoma of the prostate. J Urol 1991; 145: 907-23
6. Chybowski FM, Larson Keller JJ, Bergstralh EJ, Oesterling JE. Predicting radionucleotide bone scan findings in patients with newly diagnosed untreated prostate cancer: prostatespecific antigen is superior to all other clinical parameters. J Vrol 1991; 145: 313-8
7. Keillor JS. Altimin K. The response of poorly differentiated prostatic tumours to staining for prostate specific antigen and prostatic acid phosphatase: a comparative study. J Urol 1987: 137: 894-8
8. Cohen RJ, Haffejee Z, Steele GS, Nayler SJ. Advanced prostate cancer with normal serum prostate-specific antigen values. Arch Pathol Lab Med 1994; 118: 1123-6
9. Cohen RJ, Goldberg RD. Haffejee Z. Cohen M. Adenoid cystlike carcinoma of the prostate : an immunohistochemical study. Arch Pathol Lab Med 1993; 117: 799-801
10. Cohen RJ. Glezerson G. Haffejee Z. Prostate specific antigen and prostate specific acid phosphatase in neuroendocrine cells of prostate cancer. Ardi Pathol Lab Med 1992; 116: 65-6
11. Gleason DF. The Veterans Administration Co-Operative Urological Research Group; histological grading and clinical staging of prostatic carcinoma. In Tannenbaum M ed., Urological Pathology. Philadelphia: Lea & Febtnger. 1977: 171-98
12. Christensson A, Björk T. Nilsson O et al. Serum prostate specific antigen complexed to αl-antichymotrypsin as an indicator of prostate cancer. J Urol 1993; 150: 100-5
13. Belanger A. Rong PM. Liu S, Lavoie L, Labrie P. Characterization and measurement of prostate specificantigen using monoclonal antibodies. Clin Invest Med 1993; 16: 409-14
14. Csapo Z, Brand K, Walther R. Fokas K. Comparative experimental study of the serum prostate specific antigen and prostatic acid phosphatase in serially transplantable human prostatic carcinoma lines in nude mice. J Urol 1988: 140: 1032-7